🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Hey, something's happening in the basement ... 😀 #Fahrrad #Mobility #Bicycle Uniklinik Köln Universität zu Köln Felipe Suarez

Der Terrorangriff der Hamas auf #Israel ist jetzt bald vier Wochen her. Vieles ist seitdem passiert, die öffentliche Debatte aufgeheizt und verworren. Im Video deshalb einige Gedanken von Vizekanzler und Minister Robert #Habeck zur Einordnung und Differenzierung.

While I admire the savvy diagnostic considerations, I feel that the treatment is outdated. Caplacizumab should be frontline therapy in most patients given the accumulating evidence for clinical benefit. Our thoughts on this: bit.ly/3SyAm7i Camila Masias

The FDA has approved recombinant ADAMTS-13 for the treatment of congenital thrombotic thrombocytopenic purpura (#TTP). In the US it will be marketed under the name Adzynma.

Takeda’s #ADZYNMA (ADAMTS13, recombinant-krhn) now is approved by U.S. FDA as the First and Only a#Recombinant ADAMTS13 Enzyme Replacement Therapy for the Treatment of #Congenital Thrombotic Thrombocytopenic Purpura (cTTP)

Pre-print access to our data on the feasibility of Management of Immune Thrombotic Thrombocytopenic Purpura Without Therapeutic Plasma Exchange SSRN papers.ssrn.com/sol3/papers.cf… #TTP

Convincing data on important patient-centered outcomes. Results from an amazing world-wide collaboration! Great to be part of the international efforts! #ASH2023 #ttp #capla500

‘It’s all gone’: CAR-T therapy forces autoimmune diseases into remission nature.com/articles/d4158…

Proud to share the work by Yazan Abou-Ismail, MD - د. يزن أبواسماعيل describing fatal outcomes in iTTP using the USTMA TTP Registry! UofUHeme A Descriptive Analysis of Fatal Outcomes in Immune Thrombotic Thrombocytopenic Purpura in the USTMA TTP Registry ashpublications.org/bloodadvances/…

Some more reflections from our annual Vascular Access Meeting: Amazing presentation made by Dr. Polina Todorova who discussed the evidence on the use of direct oral anticoagulants in access surgery, both peri and postoperatively. #VascularAccess #AVF #VascularAccessCologne

How to monitor disease progression and therapy response in wild-type transthyretin amyloid cardiomyopathy? Our efforts led by Svenja Ney and Roman Pfister show there's much work to be done! Check it out: mdpi.com/2625986 #mdpijcm via JCM MDPI MDPI Universität zu Köln

Immune-mediated thrombotic thrombocytopenic purpura, ITP, and AIHA - triple hit in a patient w/systemic lupus erythematodes. Our thoughts on the management of this unusual and complex condition: DOI 10.5414/CNCS111193 pubmed.ncbi.nlm.nih.gov/38170038/ #iTTP #ITP #Lupus

Our work on #LongCovid 🩸 is now out in Science Magazine! We found increased complement activation and markers of thromboinflammation in patients with active Long Covid. 1/ doi.org/10.1126/scienc…

Vor fünf Jahren haben wir in einem Artikel dokumentiert, wie mit motorisierter Gewalt umgegangen wird. Es wird niemanden überraschen, dass es im Text auch um Natenom geht. koeln.adfc.de/artikel/kein-o…

Ein Fall, der uns letztes Jahr im konservativen Schockraum der #ukk beschäftigt hat: Atemwegsschwellung nach Trinken von Rohrreiniger | springermedizin.de Danke an alle Co-Autoren, stellvertretend ⁦Christoph Hüser⁩ und ⁦Ralf Blomeyer⁩ springermedizin.de/veraetzungen/i…

Mein Gedanken sind bei der Familie des Opfers. Ich fahre täglich mit dem Fahrrad an dieser Stelle entlang. Ein Blick auf die Verkehrsführung und das unkontrollierte Parken hier macht jedem sofort klar, wie egal der Stadt Köln die Sicherheit der Fahrradfahrer und Fußgänger ist.

One of the most pressing questions in the era of caplacizumab is if iTTP can be managed without plasma exchange! Check out our paper addressing this question: Management of Immune Thrombotic Thrombocytopenic Purpura without Therapeutic Plasma Exchange ashpublications.org/blood/article-…

Food is medicine...and what we eat governs outcome in many types of diseases (if not all). This includes solid organ transplantation. Fueling the success of transplantation through nutrition:... : Current Opinion in Organ Transplantation journals.lww.com/co-transplanta…

Our comment on Recombinant ADAMTS13 for Immune Thrombotic Thrombocytopenic Purpura | New England Journal of Medicine nejm.org/doi/full/10.10… Ralph Wendt and Paul Brinkkötter

🧵Thread on frontline caplacizumab and plasma exchange in TTP🚨 With advancing care for immune thrombotic thrombocytopenic purpura (iTTP), let’s discuss frontline caplacizumab (capla) and the future for therapeutic plasma exchange (TPE) ⤵️ #hemetwitter #TTP #caplacizumab 1/22